Looking Outside The S&P 500 For Value With 22nd Century Group The WHO's recommendation for reduced nicotine cigarettes could benefit 22nd Century Group. 5 MIN READ 04/17/2017
Emerald Health Therapeutics Primed for 2017 Growth With Trudeau’s Legalization Efforts Emerald Health Therapeutics heads into 2017 with a cash rich balance sheet. 6 MIN READ 03/09/2017
A Hat Trick Of Healthcare Hopefuls Investors can find attractive valuations in the healthcare sector. 6 MIN READ 03/06/2017
